Integra LifeSciences Holdings Corp. (IART)
14.41
+0.06
(+0.42%)
USD |
NASDAQ |
Nov 13, 16:00
14.41
0.00 (0.00%)
After-Hours: 19:59
Integra LifeSciences Holdings Market Cap : 1.121B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.117B |
| November 11, 2026 | 1.149B |
| November 10, 2026 | 1.131B |
| November 09, 2026 | 1.118B |
| November 06, 2026 | 1.044B |
| November 05, 2026 | 1.099B |
| November 04, 2026 | 1.153B |
| November 03, 2026 | 1.060B |
| November 02, 2026 | 1.059B |
| October 30, 2026 | 992.03M |
| October 29, 2026 | 998.25M |
| October 28, 2026 | 952.35M |
| October 27, 2026 | 932.89M |
| October 26, 2026 | 941.45M |
| October 23, 2026 | 926.67M |
| October 22, 2026 | 958.96M |
| October 21, 2026 | 921.22M |
| October 20, 2026 | 1.037B |
| October 19, 2026 | 1.046B |
| October 16, 2026 | 1.027B |
| October 15, 2026 | 1.052B |
| October 14, 2026 | 1.025B |
| October 13, 2026 | 1.077B |
| October 12, 2026 | 1.087B |
| October 09, 2026 | 1.045B |
| Date | Value |
|---|---|
| October 08, 2026 | 1.043B |
| October 07, 2026 | 1.011B |
| October 06, 2026 | 1.036B |
| October 05, 2026 | 1.034B |
| October 02, 2026 | 986.24M |
| October 01, 2026 | 1.251B |
| September 30, 2026 | 1.266B |
| September 29, 2026 | 1.294B |
| September 28, 2026 | 1.265B |
| September 25, 2026 | 1.254B |
| September 24, 2026 | 1.235B |
| September 23, 2026 | 1.208B |
| September 22, 2026 | 1.246B |
| September 21, 2026 | 1.213B |
| September 18, 2026 | 1.184B |
| September 17, 2026 | 1.174B |
| September 16, 2026 | 1.249B |
| September 15, 2026 | 1.220B |
| September 14, 2026 | 1.222B |
| September 11, 2026 | 1.206B |
| September 10, 2026 | 1.209B |
| September 09, 2026 | 1.264B |
| September 08, 2026 | 1.265B |
| September 04, 2026 | 1.300B |
| September 03, 2026 | 1.279B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Penumbra, Inc. | 12.65B |
| Abbott Laboratories | 187.93B |
| Globus Medical, Inc. | 9.570B |
| AngioDynamics, Inc. | 503.37M |
| Alphatec Holdings, Inc. | 1.084B |
Market Cap Related Metrics
| PE Ratio | 87.65 |
| PS Ratio | 0.6775 |
| Price to Book Value | 1.051 |
| Price to Free Cash Flow | 15.68 |
| Price | 14.41 |
| Earnings Yield | 1.14% |
| Operating PE Ratio | 5.825 |
| Normalized PE Ratio | 12.87 |